Jay Solnick, M.D., Ph.D.

Jay V. Solnick, M.D., Ph.D.


Infectious Diseases

Internal Medicine

Medical Microbiology and Immunology


  • Professor


To see if Jay V. Solnick is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).

Lawrence J. Ellison Ambulatory Care Center

4860 Y St., Suite 0101
Sacramento, CA 95817
Driving Directions

Primary Phone:

UC Davis Medical Center

2315 Stockton Blvd.
Sacramento, CA 95817
Driving Directions

Primary Phone:
800-2-UCDAVIS (800-282-3284)

Additional Phone Numbers

Physician Referrals: 800-4-UCDAVIS (800-482-3284)

Philosophy of Care

I seek to provide high value care in a thoughtful and compassionate manner.

Clinical Interests

Dr. Solnick specializes in adult infectious diseases.

Research/Academic Interests

Dr. Solnick receives NIH funding for his research laboratory that studies the gastric pathogen helicobactyer pylori, which causes peptic ulcer disease and gastric cancel. 


Infectious Diseases
Medical Microbiology and Immunology

Center/Program Affiliation

UC Davis Comprehensive Cancer Center


M.D., Columbia University, College of Physicians and Surgeons, New York, New York, 1986

Ph.D., University of North Carolina, Chapel Hill, North Carolina, 1977

B.A., UC San Diego, La Jolla, California, 1971

Internship: Internal Medicine, Stanford University, Palo Alto, California, 1986-87


Internal Medicine, Stanford University, Palo Alto, California, 1987-89


Microbiology, Pasteur Institute, Paris, 1993-1994

Infectious Diseases, Stanford University, Palo Alto, California, 1989-94

Board Certifications

American Board of Internal Medicine, 1989

American Board of Internal Medicine, Infectious Disease, 2010

Professional Memberships

American Society of Microbiology

Fellow, Infectious Diseases Society of America

Honors and Awards

Charter Member, GMPB NIH Study Section, 2010

Select Recent Publications

Ruhaak, LR, Barkauskas, DA, Torres, J, Cooke, CL, Wu, LD, Stroble, C, Ozcan, S, Williams, CC, Camorlinga, M, Rocke, DM, Lebrilla, CB and Solnick, JV.  The serum immunoglobulin G glycosylation signature of gastric cancer.  EuPA Open Proteom. 2015, 6:1-9.

Ottolini, B, Hornsby, M.J., Abujaber, R, Macarthur, Badge, JRM, Schwarzacher, T, Albertson , D, Bevins, CL, Solnick, JV, and Hollox, EJ.  Evidence of convergent evolution in humans and macaques supports an adaptive role for copy number variation of the beta-defensin-2 gene.  Genome Biol Evol. 2014, 6:3025-38.

Linz, B, Windsor, HM, McGraw, JJ ,Hansen, LM , Gajewski, JP,Tomsho,LP, Hake,CM, Solnick, JV,  Schuster, SC, and Marshall, BJ. A mutation burst during the acute phase of Helicobacter pylori infection in humans and rhesus macaques.  Nat Commun. 2014, 5:4165.

Martin, ME and Solnick, JV.  The gastric microbial community, Helicobacter pylori colonization, and disease. Gut Microbes. 2014, 5: 1-6.

Ozcan S, Barkauskas DA, Ruhaak LR, Javier Torres J, Cooke CL, An H, Hua S, Williams  CC, Dimapasoc LM, Kim J, Camorlinga-Ponce M, Rocke DM, Lebrilla C, Solnick J.V.  Serum glycan signatures of gastric cancer.  Cancer Prev Res, 2013 Dec 10. [Epub ahead of print]

Moore ME, Lam A, Bhatnagar S, Solnick JV.  Environmental determinants of transformation efficiency in Helicobacter pylori.  J Bacteriol 2013 Nov 1. [Epub ahead of print]

Martin, ME, Bhatnagar, S, George, MD, Paster, BJ, Canfield, DR, Eisen, JA, and Solnick, JV. The impact of Helicobacter pylori infection on the gastric microbiota of the rhesus macaque. PLoS ONE 2013, 8(10): e76375.

Cooke, CL, Torres, J, Solnick, JV. Biomarkers of Helicobacter pylori-associated gastric cancer.  Gut Microbes. 2013 Jul 12;4(6). [Epub ahead of print] 

Barrozo, RM, Cooke, CL, Hansen, LM, Lam, AM, Gaddy, JA, Johnson, EM, Cariaga, TA, Suarez, G, Peek, RM Jr, Cover, TL, and Solnick, JV.  Functional plasticity in the type IV secretion system of Helicobacter pylori.  PLoS Pathogens, 2013, Feb;9(2):e1003189 

Gyorke, C, Wang, S, Leslie, J, Cohen, S, Solnick, JV, Polage, CR. Evaluation of fecal C. difficile load and limit of detection during a prospective comparison of two molecular tests, the illumigene C. difficile and Xpert C. difficile/Epi.  J Clin Microbiol, 2013, 51:278-80.

Martin, ME, Dieter, JA, Luo, Z, Baumgarth, N and Solnick, JV.  Predicting the outcome of infectious diseases:  Variability among inbred mice as a new and powerful tool for biomarker discovery.  mBio, 2012 Oct 16;3(5):e00199-12.